PathoQuest

PathoQuest provides a validated Next Generation Sequencing (NGS) platform for biosafety testing, genetic characterization, and quality control of biopharmaceuticals. The company offers GMP-grade assays to detect adventitious viruses and confirm identity in products such as viral vectors, cell therapies, vaccines, and mAbs. Its services act as a contract research organization (CRO) for global biopharma companies and CDMOs, providing an animal-free alternative to traditional in vivo testing methods.